Advanced search
Publication Cover
Journal of Hepatocellular Carcinoma Volume 9, 2022 - Issue
Submit an article Journal homepage
142
Views
2
CrossRef citations to date
0
Altmetric
Original Research

Factors Associated with Survival of Hepatocellular Carcinoma (HCC) Patients at a Safety Net Hospital in Arizona without On-Site Liver Transplant Program

Erica Turse1 Department of Medicine, Creighton University School of Medicine Program, Phoenix, AZ, USAORCID Iconhttps://orcid.org/0000-0003-2270-2305
ORCID Icon,
Majd Aboona2 Department of Medicine, University of Arizona College of Medicine-Phoenix, Phoenix, AZ, USACorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-5533-8987
ORCID Icon,
Ericka Charley1 Department of Medicine, Creighton University School of Medicine Program, Phoenix, AZ, USA
,
Arnold Forlemu1 Department of Medicine, Creighton University School of Medicine Program, Phoenix, AZ, USA
,
Tessa Bowie3 Department of Research, Valleywise Health Medical Center, Phoenix, AZ, USA
,
Bikash Bhattarai3 Department of Research, Valleywise Health Medical Center, Phoenix, AZ, USA
,
Keng-Yu Chuang4 Department of Medicine, Valleywise Health Medical Center, Phoenix, AZ, USA
&
Abdul Nadir2 Department of Medicine, University of Arizona College of Medicine-Phoenix, Phoenix, AZ, USA;4 Department of Medicine, Valleywise Health Medical Center, Phoenix, AZ, USA
 show all
Pages 1-11 | Published online: 22 Jan 2022

References

  • Varela M, Bruix J. Hepatocellular carcinoma in the United States. Lessons from a population-based study in Medicare recipients. J Hepatol. 2006;44:8–10. doi:10.1016/j.jhep.2005.11.001
  • Mellinger JL, Moser S, Welsh DE, et al. Access to subspecialty care and survival among patients with liver disease. Am J Gastroenterol. 2016;111:838–844. doi:10.1038/ajg.2016.96
  • White DL, Thrift AP, Kanwal F, Davila J, El-Serag HB. Incidence of hepatocellular carcinoma in all 50 United States, from 2000 through 2012. Gastroenterology. 2017;152:812–20 e5. doi:10.1053/j.gastro.2016.11.020
  • Greten TF. Gender disparity in HCC: is it the fat and not the sex? J Exp Med. 2019;216:1014–1015. doi:10.1084/jem.20190441
  • Zheng B, Zhu YJ, Wang HY, Chen L. Gender disparity in hepatocellular carcinoma (HCC): multiple underlying mechanisms. Sci China Life Sci. 2017;60:575–584. doi:10.1007/s11427-016-9043-9
  • Mokdad AA, Murphy CC, Pruitt SL, et al. Effect of hospital safety net designation on treatment use and survival in hepatocellular carcinoma. Cancer. 2018;124:743–751. doi:10.1002/cncr.31066
  • Wang J, Ha J, Lopez A, Bhuket T, Liu B, Wong RJ. Medicaid and uninsured hepatocellular carcinoma patients have more advanced tumor stage and are less likely to receive treatment. J Clin Gastroenterol. 2018;52:437–443. doi:10.1097/MCG.0000000000000859
  • Sommers BD, Stone J, Kane N. Predictors of payer mix and financial performance among safety net hospitals prior to the affordable care act. Int J Health Serv. 2016;46:166–184. doi:10.1177/0020731415586408
  • Adler Jaffe S, Myers O, Meisner ALW, Wiggins CL, Hill DA, McDougall JA. Relationship between insurance type at diagnosis and hepatocellular carcinoma survival. Cancer Epidemiol Biomarkers Prev. 2020;29:300–307. doi:10.1158/1055-9965.EPI-19-0902
  • Serper M, Taddei TH, Mehta R, et al. Association of provider specialty and multidisciplinary care with hepatocellular carcinoma treatment and mortality. Gastroenterology. 2017;152:1954–1964. doi:10.1053/j.gastro.2017.02.040
  • Bruix J, Sherman M. American Association for the study of liver D. Management of hepatocellular carcinoma: an update. Hepatology. 2011;53:1020–1022. doi:10.1002/hep.24199
  • Kim NG, Nguyen PP, Dang H, et al. Temporal trends in disease presentation and survival of patients with hepatocellular carcinoma: a real-world experience from 1998 to 2015. Cancer. 2018;124:2588–2598. doi:10.1002/cncr.31373
  • Scaglione S, Adams W, Caines A, et al. Association between race/ethnicity and insurance status with outcomes in patients with hepatocellular carcinoma. Dig Dis Sci. 2020;65:1669–1678. doi:10.1007/s10620-019-05890-2
  • Kardashian A, Florman SS, Haydel B, et al. Liver transplantation outcomes in a U.S. Multicenter Cohort of 789 patients with hepatocellular carcinoma presenting beyond Milan criteria. Hepatology. 2020;72:2014–2028. doi:10.1002/hep.31210
  • Sanoff HK, Chang Y, Reimers M, Lund JL. Hospice utilization and its effect on acute care needs at the end of life in medicare beneficiaries with hepatocellular carcinoma. J Oncol Pract. 2017;13:e197–e206. doi:10.1200/JOP.2016.017814
  • Sellers CM, Uhlig J, Ludwig JM, et al. The impact of socioeconomic status on outcomes in hepatocellular carcinoma: inferences from primary insurance. Cancer Med. 2019;8:5948–5958. doi:10.1002/cam4.2251
  • Zhao C, Nguyen MH. Hepatocellular carcinoma screening and surveillance: practice guidelines and real-life practice. J Clin Gastroenterol. 2016;50:120–133. doi:10.1097/MCG.0000000000000446
  • Singal AG, Li X, Tiro J, et al. Racial, social, and clinical determinants of hepatocellular carcinoma surveillance. Am J Med. 2015;128:90 e1–7. doi:10.1016/j.amjmed.2014.07.027
  • Sanoff HK, Chang Y, Stavas JM, Sturmer T, Lund J. Effectiveness of initial transarterial chemoembolization for hepatocellular carcinoma among medicare beneficiaries. J Natl Compr Canc Netw. 2015;13:1102–1110. doi:10.6004/jnccn.2015.0135
  • Li J, Hansen BE, Peppelenbosch MP, De Man RA, Pan Q, Sprengers D. Factors associated with ethnical disparity in overall survival for patients with hepatocellular carcinoma. Oncotarget. 2017;8:15193–15204. doi:10.18632/oncotarget.14771

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.